This project uses a 2 x 2 factorial design to compare efficacy of two behavioral methods, relapse prevention (RP) and contingency management (CM), for reducing tobacco smoking in methadone treated opiate addicts. All subjects will receive standard transdermal nicotine patch treatment to ameliorate nicotine withdrawal symptoms, which should make comparisons between conditions meaningful. The project also evaluates associations between cigarette smoking and illicit drug use at baseline, during treatment and at follow-up. A total of 220 subjects seeking smoking cessation treatment will be randomly assigned to one of four experimental treatment groups: (1) RP only; (2) CM only; (3) combined RP + CM; and (4) neither RP nor CM - a control condition that will receive nicotine patch only. The battery of assessments to measure various dimensions of smoking include the following: Demographic information; drug use history (ASI); psychiatric diagnosis (SCID); measurement of stage of readiness for change (URICA); biological markers of smoking (CO breath levels, serum thiocyanate); physical measures of drug use (urine toxicology) self-report of smoking and drug use (Fagerstrom, TLFB); mood and physical symptoms (SCL-90-R); treatment compliance (TSR; RP Survey); and staff clinical impression (CGI). Behavioral interventions are manualized and an audiotape procedure will be used to monitor and enhance protocol compliance. The proposed project would provide a definitive controlled trial of the comparative efficacy for integrating behavioral therapies with a pharmacological treatment for smoking cessation in this high risk population. Project findings would have relevance to applied settings and to theoretical understanding of interrelationships between tobacco smoking and other drug use.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA009992-03
Application #
2749118
Study Section
Special Emphasis Panel (SRCD)
Project Start
1996-09-01
Project End
2000-07-31
Budget Start
1998-08-01
Budget End
2000-07-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Friends Research Institute, Inc.
Department
Type
DUNS #
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Yang, Xiaowei; Li, Jinhui; Shoptaw, Steven (2008) Imputation-based strategies for clinical trial longitudinal data with nonignorable missing values. Stat Med 27:2826-49
Li, Jinhui; Yang, Xiaowei; Wu, Yingnian et al. (2007) A random-effects Markov transition model for Poisson-distributed repeated measures with non-ignorable missing values. Stat Med 26:2519-32
Yang, Xiaowei; Shoptaw, Steven (2005) Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial. Drug Alcohol Depend 77:213-25
Rotheram-Fuller, Erin; Shoptaw, Steven; Berman, Steven M et al. (2004) Impaired performance in a test of decision-making by opiate-dependent tobacco smokers. Drug Alcohol Depend 73:79-86
Shoptaw, Steve; Rotheram-Fuller, Erin; Yang, Xiaowei et al. (2002) Smoking cessation in methadone maintenance. Addiction 97:1317-28; discussion 1325
Frosch, Dominick L; Nahom, Deborah; Shoptaw, Steve (2002) Optimizing smoking cessation outcomes among the methadone maintained. J Subst Abuse Treat 23:425-30
Frosch, Dominick L; Stein, Judith A; Shoptaw, Steve (2002) Using latent-variable models to analyze smoking cessation clinical trial data: an example among the methadone maintained. Exp Clin Psychopharmacol 10:258-67
Frosch, D L; Shoptaw, S; Nahom, D et al. (2000) Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals. Exp Clin Psychopharmacol 8:97-103